Loading…
U.S. Physical Therapy, Inc. is projected to rise to $89.82 by 2027, a +14% move from its current price of $79.06. USPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $77.69 | $79.10 | $80.54 | +0.05% |
| Aug 3 | $77.15 | $79.14 | $81.18 | +0.10% |
| Aug 4 | $76.74 | $79.18 | $81.69 | +0.15% |
| Aug 5 | $76.41 | $79.22 | $82.12 | +0.20% |
| Aug 6 | $76.13 | $79.26 | $82.51 | +0.25% |
| Aug 7 | $75.87 | $79.30 | $82.87 | +0.30% |
| Aug 8 | $75.64 | $79.33 | $83.21 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $75.64 | $79.33 | $83.21 | +0.35% |
| Week 2 | $74.42 | $79.61 | $85.16 | +0.70% |
| Week 3 | $73.56 | $79.89 | $86.76 | +1.05% |
| Week 4 | $72.87 | $80.16 | $88.18 | +1.40% |
| Week 5 | $72.31 | $80.44 | $89.49 | +1.75% |
| Week 6 | $71.83 | $80.72 | $90.72 | +2.10% |
| Week 7 | $71.40 | $81.00 | $91.89 | +2.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services.
The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
U.S. Physical Therapy also offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. Founded in 1990 and based in Houston, Texas, the company sits in the Healthcare sector.
This description reflects the business focus and geographic footprint as described in its public-facing profile, emphasizing outpatient therapies and prevention services for a range of clinical and corporate clients.
USPH is a healthcare company with a current price of $76.64, a market cap of $1.17B, and a market rank of 2313. The current pricing sits within a framework of a near-term forecast that sets the 2026 average at $76.64, with a minimum of $59.00 and a maximum of $95.87 and Neutral sentiment.
Looking further out, the forecast shows sustained upside, with 2030 and later years projecting higher averages—$140.46 by 2030 and $673.11 by 2050—accompanied by progressively larger ROI figures (83.3% by 2030 and 778.3% by 2050).
Overall, the price path suggests a long-run upward trajectory from a starting point around today’s level, with the potential for meaningful gains over the coming years while recognizing the inherent uncertainty in any forecast.
A major floor 28.8% below — a decisive break under it would weaken the trend.
The nearest floor, 20.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.4% away) — a breakout level to watch.
A major ceiling 15.8% above — clearing it would confirm fresh momentum.
Key USPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of USPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $78.94 | Buy | $78.58 | Buy |
| MA 10 | $76.58 | Buy | $77.01 | Buy |
| MA 20 | $74.40 | Buy | $74.64 | Buy |
| MA 50 | $68.51 | Buy | $71.54 | Buy |
| MA 100 | $70.62 | Buy | $72.01 | Buy |
| MA 200 | $76.19 | Buy | $74.60 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.11 | Neutral |
| Stoch RSI (14) | 75.07 | Neutral |
| CCI (20) | 133.74 | Buy |
| Williams %R (14) | -10.56 | Info |
| MACD (12,26,9) | 0.45 | Buy |
| ROC (12) | 10.76 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 89.44 | Sell |
| TRIX (15) | 0.53 | Buy |
| Awesome (5,34) | 7.76 | Buy |
| Ultimate (7,14,28) | 73.14 | Sell |
| Momentum (10) | 5.50 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 81.10 | Sell |
| ADX (14) | 26.35 | Buy |
| ATR (14) | 1.27 | Info |
The 30-day technical picture is bullish, with RSI(14) at 70. The price is near resistance at $76.64 and sits above the SMA50 of $66.95 while the SMA200 is at $76.46. The 30-day range spans from $66.85 to $87.86, indicating room for upside beyond the current level.
Support is identified at $62.51, providing a floor for pullbacks, while the current resistance at $76.64 marks a key hurdle for near-term upside. Traders may watch for a breakout above resistance to confirm continued near-term strength.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $59.00 | $79.06 | $99.08 | 0% | Neutral | |
| $73.65 | $89.82 | $114.46 | +14% | Neutral | |
| $85.54 | $106.30 | $139.19 | +34% | Bullish | |
| $107.13 | $135.21 | $180.85 | +71% | Bullish | |
| $118.50 | $151.59 | $206.45 | +92% | Bullish | |
| $127.67 | $165.33 | $228.73 | +109% | Bullish | |
| $135.55 | $177.52 | $249.12 | +125% | Bullish | |
| $142.59 | $188.72 | $268.28 | +139% | Bullish | |
| $161.52 | $215.91 | $310.61 | +173% | Bullish | |
| $181.98 | $245.56 | $357.22 | +211% | Bullish | |
| $257.81 | $362.88 | $553.27 | +359% | Bullish | |
| $518.61 | $782.93 | $1,279.74 | +890% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $59.00 | $79.06 | $94.13 | +0.00% |
| September 2026 | $68.24 | $80.01 | $95.95 | +1.20% |
| October 2026 | $70.22 | $82.72 | $99.93 | +3.38% |
| November 2026 | $70.25 | $83.07 | $100.96 | +0.42% |
| December 2026 | $68.33 | $81.07 | $99.08 | -2.40% |
Click any year to see its month-by-month USPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The USPH price prediction for 2026 points to an average of $79.06 (low $59.00, high $99.08) — a potential gain of 0% on today's $79.06. A consolidation phase looks the most probable path here.
In 2027, USPH is projected to trade between $73.65 and $114.46, averaging $89.82 — a potential gain of +14% from today's $79.06. That is up +14% on the projected 2026 average. Price action looks broadly range-bound.
U.S. Physical Therapy, Inc.'s 2028 outlook centres on $106.30, within a $85.54 to $139.19 range. That is up +18% on the projected 2027 average. That marks a +34% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, USPH could reach as high as $180.85, with a base case around $135.21 and support toward $107.13 — roughly +71% from $79.06. Momentum favours further upside here.
Expect USPH to range from $118.50 to $206.45 through 2030. The $151.59 average target implies a +92% move from current prices. That is up +12% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The USPH price prediction for 2031 points to an average of $165.33 (low $127.67, high $228.73) — a potential gain of +109% on today's $79.06. Momentum favours further upside here.
In 2032, USPH is projected to trade between $135.55 and $249.12, averaging $177.52 — a potential gain of +125% from today's $79.06. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
U.S. Physical Therapy, Inc.'s 2033 outlook centres on $188.72, within a $142.59 to $268.28 range. That is up +6% on the projected 2032 average. That marks a +139% change versus current levels. Momentum favours further upside here.
By 2034, USPH could reach as high as $310.61, with a base case around $215.91 and support toward $161.52 — roughly +173% from $79.06. Buyers look set to stay in control over this stretch.
Expect USPH to range from $181.98 to $357.22 through 2035. The $245.56 average target implies a +211% move from current prices. That is up +14% on the projected 2034 average. Momentum favours further upside here.
The USPH price prediction for 2040 points to an average of $362.88 (low $257.81, high $553.27) — a potential gain of +359% on today's $79.06. Buyers look set to stay in control over this stretch.
In 2050, USPH is projected to trade between $518.61 and $1,279.74, averaging $782.93 — a potential gain of +890% from today's $79.06. That is up +116% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in USPH today (≈ 12.648621 USPH) could be worth
$9,903.02
+$8,903.02 (+890%) by 2050 · US Dollar
Based on the average projected USPH price of $782.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in USPHwould be worth at today's price.
$1,000 invested in USPH on Jul 31, 2025 (≈ 13.67054 USPH) would be worth
$1,080.79
+$80.79 (+8.1%) today · 1.08× · US Dollar
Based on a USPH entry price of $73.15 vs. today's $79.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $74.58 | $1,060.07 | +6.0% |
| 1 month ago | $71.31 | $1,108.68 | +10.9% |
| 3 months ago | $71.83 | $1,100.65 | +10.1% |
| 6 months ago | $83.66 | $945.02 | -5.5% |
| 1 year ago | $73.15 | $1,080.79 | +8.1% |
| All time (5.0y) ago | $118.61 | $666.55 | -33.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our USPH forecast.
Our base-case forecast reaches $160.00 around 2031.
Implied market cap at $160.00: $2.44B
The multi-year forecast shows a clear long-term bullish trajectory. By 2026 the avg is $76.64 with a min of $59.00 and a max of $95.87 and ROI of 0, sentiment Neutral. From 2027 onward, the path lifts steadily: 2027 avg $85.89 (ROI 12.1), 2028 avg $99.61 (ROI 30), 2029 avg $125.58 (ROI 63.9), 2030 avg $140.46 (ROI 83.3).
The upward trend continues through the early 2030s and beyond: 2031 avg $151.18 (ROI 97.3), 2032 avg $161.78 (ROI 111.1), 2033 avg $171.29 (ROI 123.5), 2034 avg $192.70 (ROI 151.4), and 2035 avg $218.51 (ROI 185.1).
Beyond 2035, the forecast extends to 2040 with avg $317.24 (ROI 313.9) and 2050 with avg $673.11 (ROI 778.3). These figures imply a long-term bullish trend with substantial upside, though actual results may vary and are not guaranteed.
Tap a question to reveal the answer.
The forecasted average price in 2030 is $140.46, with a min of $108.54 and a max of $194.16, and an 83.3% ROI.
Forecasts show rising averages and positive ROIs in subsequent years, with 2026 at $76.64 (ROI 0) and 2027 onward climbing to $85.89, $99.61, and $125.58 by 2029, culminating in an $140.46 average in 2030 and a long-run upside to $673.11 by 2050 (ROI 778.3%).
Yes. The max forecast shows higher-price scenarios: 2033 max $248.01, 2034 max $282.62, and 2035 max $324.34, with 2030 max $194.16.
Current price is $76.64 and market cap is $1.17B.
RSI(14) is 70 with bullish sentiment; SMA50 is $66.95, SMA200 is $76.46; support is $62.51 and resistance is $76.64; the 30-day range runs from $66.85 to $87.86.
U.S. Physical Therapy, Inc. Community Discussion
0Share your U.S. Physical Therapy, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.